DAN J. MITCHELL - Corporate Board Profile

Oruka Therapeutics, Inc.

Filing Date	Source Excerpt
2014-04-15	Mr. Mitchell, age 57, was appointed to the ARCA Board of Directors in February 2014. ... The Audit Committee is currently composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Woosley. ... The Compensation Committee is currently composed of three directors: Mr. Robert Conway, Dr. Linda Grais (chair) and Dr. Raymond Woosley. ... The Nominating and Corporate Governance Committee is currently composed of three directors, Dr. Grais, Mr. Mitchell and Dr. Woosley. ... On February 11, 2014, Mr. Mitchell joined the Board.
2015-04-14	Mr. Mitchell, age 58, was appointed to the ARCA Board of Directors in February 2014. He founded and is a manager of Sequel Venture Partners, L.L.C., a venture capital firm formed in January 1997. Prior to founding Sequel Venture Partners, Mr. Mitchell was a founder of Capital Health Venture Partners, a health care focused venture capital firm, where he was a General Partner from October 1986 until 2006, and he was in the Venture Capital Division of the Trust Department of the First National Bank of Chicago from 1983 to 1985. He currently serves on the board of directors of GlobeImmune, Inc., a publicly traded biopharmaceutical company, and several private companies. Mr. Mitchell holds a B.S. from the University of Illinois and an M.B.A. from the University of California at Berkeley. Mr. Mitchell is an appropriate member of the Company’s Board of Directors given his expertise and experience in the pharmaceutical industry, pharmaceutical development, and in corporate finance and governance. Director Compensation for fiscal 2014: $61,070.
2016-04-27	Mr. Mitchell, age 59, was appointed to the Board of Directors in February 2014. ... The Audit Committee is currently composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Woosley. ... The Compensation Committee is currently composed of three directors: Mr. Robert Conway, Dr. Linda Grais (chair) and Dr. Raymond Woosley. ... The Nominating and Corporate Governance Committee is currently composed of three directors, Dr. Grais, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for fiscal 2015: Dan J. Mitchell Fees Earned or Paid in Cash ($) 40,000, Option Awards ($) 3,645, Total ($) 43,645.
2017-04-21	Mr. Mitchell, age 60, was appointed to the Board of Directors in February 2014. ... In the fiscal year ended December 31, 2016, the Audit Committee was composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Woosley. ... The Compensation Committee is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... Director Compensation for Mr. Mitchell for fiscal 2016 was $64,979.
2018-04-18	Mr. Mitchell, age 61, was appointed to the Board of Directors in February 2014. He founded, and is a manager of Sequel Venture Partners, L.L.C., a venture capital firm formed in January 1997. Prior to founding Sequel Venture Partners, Mr. Mitchell was a founder of Capital Health Venture Partners, a health care focused venture capital firm, where he was a General Partner from October 1986 until 2006, and he was in the Venture Capital Division of the Trust Department of the First National Bank of Chicago from 1983 to 1985. He currently serves on the board of directors of several private companies. Mr. Mitchell holds a B.S. from the University of Illinois and an M.B.A. from the University of California at Berkeley. We believe Mr. Mitchell is an appropriate member of the Board of Directors given his expertise and experience in the pharmaceutical industry, pharmaceutical development, and in corporate finance and governance. Director Compensation For fiscal year ended December 31, 2017, Mr. Mitchell received $47,500 in fees earned or paid in cash and $12,220 in option awards, totaling $59,720.
2018-09-20	The following table sets forth certain information regarding the ownership of the Companys Common Stock as of the August 31, 2018, by: (i) each director and nominee for director, (ii) each of our named executive officers, (iii) all executive officers and directors of the Company as a group, and (iv) all those known by the Company to be beneficial owners of more than five percent of its Common Stock.
2019-10-25	Mr. Mitchell, age 62, was appointed to the Board of Directors in February 2014. ... The Audit Committee is composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Grais. ... The Nominating and Corporate Governance Committee is composed of three directors: Dr. Hove, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for Fiscal 2018 ... Dan J. Mitchell ... $52,140.
2020-10-28	Dan J. Mitchell Mr. Mitchell, age 63, was appointed to the Board of Directors in February 2014. ... The Nominating and Corporate Governance Committee is composed of three directors: Dr. Hove, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for Fiscal 2019 shows Mr. Mitchell received $47,500 in cash fees.
2021-04-21	Mr. Mitchell, age 64, was appointed to the Board of Directors in February 2014. ... We believe Mr. Mitchell is an appropriate member of the Board of Directors given his expertise and experience in the pharmaceutical industry, pharmaceutical development, and in corporate finance and governance. ... The Audit Committee was composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Grais. ... The Compensation Committee of the Board of Directors, or the Compensation Committee, is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... The Nominating and Corporate Governance Committee is composed of three directors: Dr. Hove, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for Fiscal 2020 ... Dan J. Mitchell ... $47,500 ...
2022-11-03	Mr. Mitchell, age 65, was appointed to the Board of Directors in February 2014. ... The Audit Committee was composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Grais. ... The Compensation Committee of the Board of Directors, or the Compensation Committee, is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... The Nominating and Corporate Governance Committee of the Board of Directors, or the Nominating and Corporate Governance Committee, is composed of three directors: Dr. Hove, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for Fiscal 2021 ... Dan J. Mitchell ... Fees Earned or Paid in Cash ($) 51,250 ... Option Awards ($) 39,187 ... Total ($) 90,437.
2023-12-19	Mr. Mitchell, age 66, was appointed to the Board of Directors in February 2014. ... He serves on the Audit Committee and Compensation Committee. Director compensation for 2022 was $63,836.